Category: Ondine In The News

Ondine’s MRSAid Photodisinfection Technology Featured On National Canadian News

We couldn’t be any more excited by this! After announcing the results of our Vancouver General Hospital project, we were featured on national canadian news.  In this year-long quality improvement project, patients entering major select surgeries were treated with MRSAid Photodisinfection System and chlorhexidine body wipes. This was done to reduce their risk of developing surgical site infections. Here are highlights of the data:

  • Surgical site infections were reduced by 39%
  • Vancouver General Hospital saved ~$1.9 million
  • Readmissions due to surgical site infections decreased from 4 to 1.25 cases/month
  • 553 patient bed days were freed up
  • 138 more surgeries could be performed

We are grateful for the amazing work Dr. Elizabeth Bryce and her team at Vancouver General Hospital team has done to integrate MRSAid into their workflow. Check out these videos:

Read More

Avoiding Unwanted Christmas ‘Gifts’: Holiday Precautions Against Infection

As the old saying goes, ‘Christmas is a time for giving’—a time to share gifts and reconnect with friends, family, and loved ones.  It’s also the time of year that many of us get sick and unintentionally spread illness to all those around us— whether it’s a cold, flu, or bacterial infection.  While receiving socks and underwear under the tree may be disappointing— or downright depressing—coughing or vomiting through the holiday season doesn’t exactly make for fond yuletide memories or warm Christmas cheer.

In fact, lining up for the bathroom after eating a partially cooked turkey has been known to scar even the most diehard Santa fans.  So, in the true spirit of Christmas prevention, we’ve come up with a short list of health tips, so you and your loved ones can avoid a less than ideal holiday experience.

Read More

Ondine CEO, Carolyn Cross, Survives Plane Crash: “I Am More Dedicated To PDT Than Ever”

Update: Carolyn would like to thank everyone for their well wishes. She is currently at home recovering from knee surgery and we expect her to make a full recovery soon. Please send donations to the family of the pilot, Luc Fortin, to support his 16-month old daughter – inmemoryofluc@shaw.ca

Miracles really do happen. On Thursday October 27th, Carolyn Cross (our CEO, Chairman, and dear friend) survived a deadly plane crash. On a chartered flight headed to Kelowna, Carolyn knew something wasn’t right when the pilot told passengers there was an oil leak and they were returning to the airport. “I looked at his hands and they were shaking, trembling,” Carolyn said in an interview from her hospital bed, “At that moment I knew we were going to die.” Carolyn then calmly took out her phone and began typing out farewell messages to her three young kids, “Something that they would remember me by, that I could have peace that I had said my goodbyes.”

Seconds later, Carolyn’s plane crashed on a busy road about 900 meters short of the runway. “We crashed and I immediately looked outside because I was at a door window and it was full of flames outside. So I couldn’t go out. It smelled full of gasoline….I went to get up and I could not walk. It was as if I had no legs, as if they were blown off. And I thought of my children, and God and the universe gave me the energy and I got up to the door. I said I don’t know what I am going to do now because I can’t get out of the plane, my legs, I can’t get out of the plane.”

Read More

Ondine To Launch Ventilator-Associated Pneumonia (VAP) Photodisinfection Clinical Study

We are thrilled to announce that the FDA has approved a human clinical study to investigate the use of photodisinfection to prevent ventilator-associated pneumonia (VAP). VAP occurs when a lung infection develops in a patient ventilated with an endotracheal tube and continues to be the #1 cause of healthcare-associated infections in intensive care units. In the U.S alone, more than 1.3 million patients are mechanically ventilated every year. Of these patients, 10%-20% will develop ventilator-associated pneumonia, and up to half of them will die.

“A successful VAP study would represent a key step towards the commercialization of this new application of photodisinfection which utilizes Ondine’s patented technology and products…(our technology) has been proven to be highly effective at eliminating biofilms in ex vivo models, it is therefore ideally suited for the elimination of endotracheal tube biofilms resulting in the prevention of VAP” says Carolyn Cross, Chairman & CEO of Ondine.

Read More

Ondine CEO, Carolyn Cross, Inducted Onto The Board of the International Photodynamic Association

“We have spent the last 70 years using and misusing antibiotics to treat and prevent common infectious diseases…It is therefore imperative that non-antibiotic solutions to fight infections are developed in order to preserve the next generation of effective medicine.”

Carolyn Cross Inducted Onto Board of IPA

Our CEO has done it again. Two weeks after being featured in the Vancouver Sun Newspaper, Ms. Cross has now been inducted onto the Board of the International Photodynamic Association (IPA). Founded in 1986, the IPA brings together the most distinguished international clinicians and scientists involved in researching and developing photodynamic therapy. Ms. Cross will help raise awareness about the benefits of this technology and help bring it to the forefront of medicine.

We are very pleased to share this announcement with all of you today. Ms. Cross has been with Ondine for over a decade and was one of the initial founders and financial supporters of our company. Under her leadership, Ondine has developed a rapid R & D program and is now seen as one of the world’s most renowned group of experts on photodynamic therapy and photodisinfection. Read More

Ondine Chairman & CEO, Carolyn Cross, Featured In Vancouver Sun Newspaper

Carolyn Cross, Chairman & CEO of Ondine Biomedical Inc, understands too well the importance of supporting women in business.  This week, the Vancouver Sun Newspaper highlighted her involvement & support for this week’s Women Presidents’ Organization (WPO) International Conference. This is a unique event that connects highly successful women from around the world in promoting the advancement of women across all industries. The WPO is an exclusive membership organization for women presidents of multimillion-dollar companies. Collectively, members of the WPO have 24,000 years in business, generate $14 billion in annual revenues, and employ 105,000 employees.

Carolyn Cross, Chairman & CEO of Ondine Biomedical Inc, was featured in today's Vancouver Sun Newspaper

Read More

MRSAid™ & VGH Infection Control Project Featured on Canadian National News!

Last Friday, we announced an innovative partnership with Vancouver General Hospital (VGH), one of Canada`s largest hospitals. Today, we are very excited to have this partnership featured on Global News.

MRSAidTM is a non-antibiotic therapy designed to eliminate bacteria in the noses of patients during high infection risk times. Pathogenic bacteria such as Staphylococcus aureus and MRSA can significantly increase the risk of a patient developing serious infections after surgery. As part of our partnership with VGH, MRSAidTM will be used on patients undergoing cardiac, spinal, breast reconstruction, thoracic, neurological, and orthopaedic surgeries. We are very excited to be working with the leaders in infection control at VGH. For more information on MRSAidTM, please visit www.mrsaid.com. Also, connect with us on TwitterFacebook, we`ll be happy to respond to any of your comments and questions.

Ondine To Participate in Vancouver General Hospital Infection Control Project

MRSAid product by Ondine Biomedical

World Health Day is celebrated on the 7th of April every year to mark the establishment of the World Health Organization (WHO). Each year, the WHO selects a key health issue and encourages people from around the world to hold events and promote actions that will improve health. It is very fitting for Ondine then that this year’s World Health Day theme is “Combating Drug Resistance.” We have spent the last 70 years using and misusing antibiotics to treat and prevent common infectious diseases. Today, we have entered an era where bacteria have developed the ability to become resistant to most antibiotics, rendering them almost useless. It is therefore imperative that non-antibiotic solutions to fight infections are developed in order to preserve the next generation of effective medicine. Read More

Related Posts Plugin for WordPress, Blogger...

Staypressed theme by Themocracy